A critical role for CD8 T cells in a nonhuman primate model of tuberculosis
- PMID: 19381260
- PMCID: PMC2663842
- DOI: 10.1371/journal.ppat.1000392
A critical role for CD8 T cells in a nonhuman primate model of tuberculosis
Abstract
The role of CD8 T cells in anti-tuberculosis immunity in humans remains unknown, and studies of CD8 T cell-mediated protection against tuberculosis in mice have yielded controversial results. Unlike mice, humans and nonhuman primates share a number of important features of the immune system that relate directly to the specificity and functions of CD8 T cells, such as the expression of group 1 CD1 proteins that are capable of presenting Mycobacterium tuberculosis lipids antigens and the cytotoxic/bactericidal protein granulysin. Employing a more relevant nonhuman primate model of human tuberculosis, we examined the contribution of BCG- or M. tuberculosis-elicited CD8 T cells to vaccine-induced immunity against tuberculosis. CD8 depletion compromised BCG vaccine-induced immune control of M. tuberculosis replication in the vaccinated rhesus macaques. Depletion of CD8 T cells in BCG-vaccinated rhesus macaques led to a significant decrease in the vaccine-induced immunity against tuberculosis. Consistently, depletion of CD8 T cells in rhesus macaques that had been previously infected with M. tuberculosis and cured by antibiotic therapy also resulted in a loss of anti-tuberculosis immunity upon M. tuberculosis re-infection. The current study demonstrates a major role for CD8 T cells in anti-tuberculosis immunity, and supports the view that CD8 T cells should be included in strategies for development of new tuberculosis vaccines and immunotherapeutics.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.Mol Med. 2012 May 9;18(1):647-58. doi: 10.2119/molmed.2011.00222. Mol Med. 2012. PMID: 22396020 Free PMC article.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.J Virol. 2021 Jan 28;95(4):e01718-20. doi: 10.1128/JVI.01718-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33087465 Free PMC article.
-
Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.J Nanobiotechnology. 2022 Jan 15;20(1):36. doi: 10.1186/s12951-021-01234-3. J Nanobiotechnology. 2022. PMID: 35033108 Free PMC article.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
Cited by
-
Immune correlates of protection as a game changer in tuberculosis vaccine development.NPJ Vaccines. 2024 Oct 30;9(1):208. doi: 10.1038/s41541-024-01004-w. NPJ Vaccines. 2024. PMID: 39478007 Free PMC article. Review.
-
IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB.J Immunol. 2012 May 1;188(9):4278-88. doi: 10.4049/jimmunol.1101291. Epub 2012 Apr 2. J Immunol. 2012. PMID: 22474020 Free PMC article.
-
Quest for correlates of protection against tuberculosis.Clin Vaccine Immunol. 2015 Mar;22(3):258-66. doi: 10.1128/CVI.00721-14. Epub 2015 Jan 14. Clin Vaccine Immunol. 2015. PMID: 25589549 Free PMC article. Review.
-
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.J Immunol. 2013 Sep 1;191(5):2514-2525. doi: 10.4049/jimmunol.1301161. Epub 2013 Jul 31. J Immunol. 2013. PMID: 23904160 Free PMC article.
-
The non-human primate model of tuberculosis.J Med Primatol. 2012 Jun;41(3):191-201. doi: 10.1111/j.1600-0684.2012.00536.x. Epub 2012 Mar 20. J Med Primatol. 2012. PMID: 22429048 Free PMC article. Review.
References
-
- Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007;196(Suppl 1):S86–107. - PubMed
-
- Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 2005;366:1443–1451. - PubMed
-
- Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29–35. - PubMed
-
- Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22:1154–1158. - PubMed
-
- Fine PE. BCG: the challenge continues. Scand J Infect Dis. 2001;33:243–245. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
